Arkolith/Insider Trading/FULC/Form 4

Gould Robert J

DirectorFulcrum Therapeutics, Inc. (FULC) · full profile →Form 4 · filed Jun 6, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$533K
Net Open-Market Flow
-$533K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 6, 2022Sell(S)24K$8.10$197K507K
Jun 6, 2022Option exercise(M)24K$7.84$191K531K
Jun 3, 2022Option exercise(M)26K$7.84$200K532K
Jun 3, 2022Sell(S)26K$7.95$203K507K
Jun 2, 2022Sell(S)17K$7.92$132K507K
Jun 2, 2022Option exercise(M)17K$7.84$131K523K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 6, 2022Option exercise(M)24K—$0158K
Jun 3, 2022Option exercise(M)26K—$0182K
Jun 2, 2022Option exercise(M)17K—$0208K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-021250) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML